Safety and Risk of Pharmacotherapy

OCT 4, 2026 · JOURNAL ARTICLE

Active Development Portfolio for Obesity Pharmacotherapy: An Analysis of Data from the ClinicalTrials.gov Registry

Safety and Risk of Pharmacotherapy

INTRODUCTION. The success of incretin receptor agonists has changed the standard of obesity pharmacotherapy and has stimulated both the development of incremental innovations based

OCT 4, 2026 · JOURNAL ARTICLE

Personalization and Safety of Pharmacotherapy: Evolution of Approaches to the Treatment of Obesity and Eating Disorders

Safety and Risk of Pharmacotherapy

The rapid increase in the prevalence of obesity and the rise in eating disorders require a revision of treatment approaches. Modern clinical practice supplements the therapeutic ar